|
 |
| home > epc > spring 2003 > trademarks in russia - a fight against counterfeiting and unfair competition |
|
|
 PUBLICATIONS |
European Pharmaceutical Contractor
|
Trademarks are meant to protect their owner from unauthorised use of their brand name by others. This instrument of legal protection was practically forgotten in the time of the Soviet Union, but in the past decade it has been gathering strength steadily thanks to the new conditions of the Russian market economy, favourable both in terms of fair business and unfair competition.
Protection of trademarks in the pharmaceutical industry is a matter of particular importance. There are two kinds of trademark misuse. A trademark can be copied exactly together with replica packaging; this constitutes a case of counterfeit product. Alternatively, an unfair competitor can create a design similar enough to the original that it can mislead a consumer as to the producer of the drug. Nowadays both kinds of infringement are to be observed in the Russian market.
From the consumer's point of view, a counterfeit or false drug can seriously affect health. From the point of view of a specialist, a counterfeit drug accompanied by false information regarding its content or its producer infringes rights protected by patents and trademarks.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
4th Annual Patient Recruitment and Retention in Clinical Trials
13-15 October 2008, Amsterdam
Patient recruitment
is now consuming thirty percent of clinical trial time - more time than any
other clinical trial activity - and almost half of all trial delays result from
patient recruitment problems.
As the
recruiting culture becomes more sophisticated and the forces affecting patient
enrollment grow more numerous and complex, pharmaceutical companies are
striving to discover new strategies to facilitate enrollment in clinical
trials.
With
increasing industry pressure to develop, test and market greater numbers of new
drugs faster, pharmaceutical companies need to perform clinical trials as
quickly as possible. Inefficient patient recruitment processes is a formidable
barrier to pharmaceutical companies' success in launching new products.
Improving the patient recruitment process is imperative to avoid wasted
investments and eliminate costly delays in bringing new drugs to market --
today and even more so in the not-so-distant future. Improved patient
recruitment presents one of the largest opportunities for pharmaceutical
companies to eliminate delays in clinical trials, thereby making it possible to
reduce time to market. With patent time limits and large overheads
meaning that any delays in the development timeline can be disastrous, a good
understanding of how to successfully recruit patients for trials is vital for
any company looking to succeed.
More info >> |
|
 |
News and Press Releases |
 |
New PFA SonicLineŽ ultrasonic flowmeters
Flow measurement with ultrasound fast, precise, free from contamination The new PFA SonicLineŽ ultrasonic flowmeters assure precise measurement and control of chemical consumption and management of chemical stocks with high reliability. SonicLineŽ is also ideally suited for accurate batch and dosing processes with high reproducibility.
More info >> |
|
 |
